Focal pulsed field ablation and ultrahigh-density mapping - versatile tools for all atrial arrhythmias? Initial procedural experiences.
Atrial fibrillation
Electrophysiology
Mapping
Pulsed field ablation
Safety
Ultrahigh density
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
30 May 2023
30 May 2023
Historique:
received:
17
04
2023
accepted:
16
05
2023
medline:
30
5
2023
pubmed:
30
5
2023
entrez:
30
5
2023
Statut:
aheadofprint
Résumé
Focal pulsed field ablation (FPFA) is a novel and promising method of cardiac ablation. The aim of this study was to report the feasibility, short-term safety, and procedural findings for a broad spectrum of ablated atrial arrhythmias. Patients (n = 51) scheduled for ablation of atrial arrhythmias were prospectively included and underwent FPFA using the Galvanize CENTAURI generator with energy delivery through commercially available ablation catheters with ultrahigh-density (UHDx) 3D electroanatomic voltage/local activation time map evaluations. Workflow, procedural data, and peri-procedural technical errors and complications are described. Planned ablation strategy was achieved with FPFA-only in 48/51 (94%) of the cases. Ablation strategy was first-time pulmonary vein isolation (PVI) in 17/51 (36%), repeat ablation in 18/51 (38%), PVI + in 13/51 (28%), and cavotricuspid isthmus block (CTI)-only in 3/51 (6%). The mean procedure time was 104 ± 31 min (first-time PVI), 114 ± 26 min (repeat procedure), 152 ± 36 min (PVI +), and 62 ± 17 min (CTI). Mean UHDx mapping time to assess lesion formation and block after ablation was 7 ± 4 min with 5485 ± 4809 points. First pass acute (linear) isolation with bidirectional block for anatomical lesion sets was 120/124 (97%) for all PVs, 17/17 (100%) for (any) isthmus, and 14/17 (82%) for left atrium posterior wall (LAPW). We observed several time-consuming integration errors with the used ablation system (mean 3.4 ± 3.7 errors/procedure), one transient inferior ST elevation when ablating CTI resolved by intravenous nitroglycerine and one transient AV block requiring temporary pacing for > 24 h. FPFA was a highly versatile method to treat atrial arrhythmias with high first-pass efficiency. UHDx revealed acute homogenous low-voltage lesions in ablated areas. More data is needed to establish lesion durability and limitations of FPFA.
Sections du résumé
BACKGROUND
BACKGROUND
Focal pulsed field ablation (FPFA) is a novel and promising method of cardiac ablation. The aim of this study was to report the feasibility, short-term safety, and procedural findings for a broad spectrum of ablated atrial arrhythmias.
METHODS
METHODS
Patients (n = 51) scheduled for ablation of atrial arrhythmias were prospectively included and underwent FPFA using the Galvanize CENTAURI generator with energy delivery through commercially available ablation catheters with ultrahigh-density (UHDx) 3D electroanatomic voltage/local activation time map evaluations. Workflow, procedural data, and peri-procedural technical errors and complications are described.
RESULTS
RESULTS
Planned ablation strategy was achieved with FPFA-only in 48/51 (94%) of the cases. Ablation strategy was first-time pulmonary vein isolation (PVI) in 17/51 (36%), repeat ablation in 18/51 (38%), PVI + in 13/51 (28%), and cavotricuspid isthmus block (CTI)-only in 3/51 (6%). The mean procedure time was 104 ± 31 min (first-time PVI), 114 ± 26 min (repeat procedure), 152 ± 36 min (PVI +), and 62 ± 17 min (CTI). Mean UHDx mapping time to assess lesion formation and block after ablation was 7 ± 4 min with 5485 ± 4809 points. First pass acute (linear) isolation with bidirectional block for anatomical lesion sets was 120/124 (97%) for all PVs, 17/17 (100%) for (any) isthmus, and 14/17 (82%) for left atrium posterior wall (LAPW). We observed several time-consuming integration errors with the used ablation system (mean 3.4 ± 3.7 errors/procedure), one transient inferior ST elevation when ablating CTI resolved by intravenous nitroglycerine and one transient AV block requiring temporary pacing for > 24 h.
CONCLUSIONS
CONCLUSIONS
FPFA was a highly versatile method to treat atrial arrhythmias with high first-pass efficiency. UHDx revealed acute homogenous low-voltage lesions in ablated areas. More data is needed to establish lesion durability and limitations of FPFA.
Identifiants
pubmed: 37249807
doi: 10.1007/s10840-023-01570-4
pii: 10.1007/s10840-023-01570-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614–27.
doi: 10.1016/j.jacep.2021.02.014
pubmed: 33933412
Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74(3):315–26.
doi: 10.1016/j.jacc.2019.04.021
pubmed: 31085321
Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022;24(8):1256–66.
doi: 10.1093/europace/euac050
pubmed: 35647644
pmcid: 9435639
Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FE, et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation. 2023;147(19):1422–32.
doi: 10.1161/CIRCULATIONAHA.123.063988
pubmed: 36877118
pmcid: 10158608
Duytschaever M, De Potter T, Grimaldi M, Anic A, Vijgen J, Neuzil P, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol. 2023;16(3):e011780.
doi: 10.1161/CIRCEP.122.011780
pubmed: 36735937
pmcid: 10026968
Neven K, Futing A, Byrd I, Heil RW Jr, Fish JM, Feeney DA, et al. Absence of (sub-)acute cerebral events or lesions after electroporation ablation in the left-sided canine heart. Heart Rhythm. 2021;18(6):1004–11.
doi: 10.1016/j.hrthm.2021.02.015
pubmed: 33617997
Neven K, van Es R, van Driel V, van Wessel H, Fidder H, Vink A, et al. Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus. Circ Arrhythm Electrophysiol. 2017;10(5). https://doi.org/10.1161/CIRCEP.116.004672 .
Koruth JS, Kuroki K, Kawamura I, Brose R, Viswanathan R, Buck ED, et al. Pulsed field ablation versus radiofrequency ablation: esophageal injury in a novel porcine model. Circ Arrhythm Electrophysiol. 2020;13(3):e008303.
doi: 10.1161/CIRCEP.119.008303
pubmed: 31977250
pmcid: 7069397
Koruth JS, Kuroki K, Kawamura I, Stoffregen WC, Dukkipati SR, Neuzil P, et al. Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability. Circ Arrhythm Electrophysiol. 2020;13(6):e008716.
doi: 10.1161/CIRCEP.120.008716
pubmed: 32370542
Ruwald MH, Johannessen A, Hansen ML, Haugdal M, Worck R, Hansen J. Pulsed field ablation in real-world atrial fibrillation patients: clinical recurrence, operator learning curve and re-do procedural findings. J Interv Card Electrophysiol. 2023. https://doi.org/10.1007/s10840-023-01495-y .
doi: 10.1007/s10840-023-01495-y
pubmed: 36753029
Reddy VY, Petru J, Funasako M, Kopriva K, Hala P, Chovanec M, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation. 2022;146(24):1808–19.
doi: 10.1161/CIRCULATIONAHA.122.061497
pubmed: 36134574
Schmidt B, Bordignon S, Tohoku S, Chen S, Bologna F, Urbanek L, et al. 5S study: safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation. Circ Arrhythm Electrophysiol. 2022;15(6):e010817.
doi: 10.1161/CIRCEP.121.010817
pubmed: 35617232
Lemoine MD, Fink T, Mencke C, Schleberger R, My I, Obergassel J, et al. Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario. Clin Res Cardiol. 2022. https://doi.org/10.1007/s00392-022-02091-2 .
Verma A, Neal R, Evans J, Castellvi Q, Vachani A, Deneke T, et al. Characteristics of pulsed electric field cardiac ablation porcine treatment zones with a focal catheter. J Cardiovasc Electrophysiol. 2023;34(1):99–107.
doi: 10.1111/jce.15734
pubmed: 36335638
Duytschaever M, De Pooter J, Demolder A, El Haddad M, Phlips T, Strisciuglio T, et al. Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: the CLOSE to CURE study. Heart Rhythm. 2020;17(4):535–43.
doi: 10.1016/j.hrthm.2019.11.004
pubmed: 31707159
Ruwald MH, Johannessen A, Hansen ML, Haugdal M, Worck R, Hansen J. Utility of high-density 3D-bipolar voltage map after pulmonary vein isolation by pulsed-field ablation. JACC Clin Electrophysiol. 2023. https://doi.org/10.1016/j.jacep.2022.11.030 .
doi: 10.1016/j.jacep.2022.11.030
pubmed: 36752456
Vicera JJB, Lin YJ, Lee PT, Chang SL, Lo LW, Hu YF, et al. Identification of critical isthmus using coherent mapping in patients with scar-related atrial tachycardia. J Cardiovasc Electrophysiol. 2020;31(6):1436–47.
doi: 10.1111/jce.14457
pubmed: 32227530
pmcid: 7383970
Ruwald MH, Johannessen A, Hansen ML, Worck R, Hansen J. Pulsed field ablation of the cavotricuspid isthmus using a multispline-electrode pulsed field ablation catheter. HeartRhythm Case Rep. 2022;8(3):147–50.
doi: 10.1016/j.hrcr.2021.12.009
pubmed: 35492844
Bohnen M, Weber R, Minners J, Jadidi A, Eichenlaub M, Neumann FJ, et al. Characterization of circumferential antral pulmonary vein isolation areas resulting from pulsed-field catheter ablation. Europace. 2022;25(1):65–73. https://doi.org/10.1093/europace/euac111 .
doi: 10.1093/europace/euac111
pmcid: 10103571
Gunawardene MA, Schaeffer BN, Jularic M, Eickholt C, Maurer T, Akbulak RO, et al. Pulsed-field ablation combined with ultrahigh-density mapping in patients undergoing catheter ablation for atrial fibrillation: practical and electrophysiological considerations. J Cardiovasc Electrophysiol. 2022;33(3):345–56.
doi: 10.1111/jce.15349
pubmed: 34978360
Tohoku S, Chun KRJ, Bordignon S, Chen S, Schaack D, Urbanek L, et al. Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation. Europace. 2022;25(2):433–40. https://doi.org/10.1093/europace/euac211 .
doi: 10.1093/europace/euac211
pmcid: 9935020
Vlachos K, Efremidis M, Derval N, Martin CA, Takigawa M, Bazoukis G, et al. Use of high-density activation and voltage mapping in combination with entrainment to delineate gap-related atrial tachycardias post atrial fibrillation ablation. Europace. 2021;23(7):1052–62.
doi: 10.1093/europace/euaa394
pubmed: 33564832
Sanders P, Jais P, Hocini M, Hsu LF, Scavee C, Sacher F, et al. Electrophysiologic and clinical consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm. 2004;1(2):176–84.
doi: 10.1016/j.hrthm.2004.03.072
pubmed: 15851150
Reddy VY, Anic A, Koruth J, Petru J, Funasako M, Minami K, et al. Pulsed field ablation in patients with persistent atrial fibrillation. J Am Coll Cardiol. 2020;76(9):1068–80.
doi: 10.1016/j.jacc.2020.07.007
pubmed: 32854842
Phlips T, Verhaeghe L, Antole N, Koopman P, Vijgen J. Pulsed field ablation using a focal contact force catheter allowed successful ablation of a focal right atrial tachycardia in the proximity of the phrenic nerve. HeartRhythm Case Rep. 2023. https://doi.org/10.1016/j.hrcr.2023.03.016 .
doi: 10.1016/j.hrcr.2023.03.016
Nakagawa H, Castellvi Q, Neal R, Girouard S, Ikeda A, Kuroda S, et al. Effects of contact force on lesion size during pulsed field ablation. Heart Rhythm. 2021;18(PO03-131):S242–3.
doi: 10.1016/j.hrthm.2021.06.605
Worck R, Sorensen SK, Johannessen A, Ruwald M, Haugdal M, Hansen J. Posterior wall isolation in persistent atrial fibrillation feasibility, safety, durability, and efficacy. J Cardiovasc Electrophysiol. 2022;33(8):1667–74.
doi: 10.1111/jce.15556
pubmed: 35598313
pmcid: 9543717
Worck R, Sorensen SK, Johannessen A, Ruwald MH, Hansen ML, Haugdal M, et al. Posterior wall isolation in persistent atrial fibrillation. Long-term outcomes of a repeat procedure strategy. J Interv Card Electrophysiol. 2023;66(4):971–9. https://doi.org/10.1007/s10840-022-01402-x .
doi: 10.1007/s10840-022-01402-x
pubmed: 36327059
Kistler PM, Chieng D, Sugumar H, Ling LH, Segan L, Azzopardi S, et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA. 2023;329(2):127–35.
doi: 10.1001/jama.2022.23722
pubmed: 36625809